Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity

Journal of Medicinal Chemistry
2019.0

Abstract

Various mechanisms for regulated cell death include the formation of oxidative mediators such as lipid peroxides and nitric oxide (NO). In this respect, 15-lipoxygenase-1 (15-LOX-1) is a key enzyme that catalyzes the formation of lipid peroxides. The actions of these peroxides are interconnected with nuclear factor-κB signaling and NO production. Inhibition of 15-LOX-1 holds promise to interfere with regulated cell death in inflammatory conditions. In this study, a novel potent 15-LOX-1 inhibitor, 9c (i472), was developed and structure-activity relationships were explored. In vitro, this inhibitor protected cells from lipopolysaccharide-induced cell death, inhibiting NO formation and lipid peroxidation. Thus, we provide a novel 15-LOX-1 inhibitor that inhibits cellular NO production and lipid peroxidation, which set the stage for further exploration of these mechanisms.

Knowledge Graph

Similar Paper

Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity
Journal of Medicinal Chemistry 2019.0
Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties
Journal of Medicinal Chemistry 2015.0
Design, synthesis, and 5-lipoxygenase-inhibiting properties of 1-thio-substituted butadienes
Journal of Medicinal Chemistry 1990.0
Recent development of lipoxygenase inhibitors as anti-inflammatory agents
MedChemComm 2017.0
Naphthalenic Lignan Lactones as Selective, Nonredox 5-Lipoxygenase Inhibitors. Synthesis and Biological Activity of (Methoxyalkyl)thiazole and Methoxytetrahydropyran Hybrids
Journal of Medicinal Chemistry 1994.0
Pseudoperoxidase investigations of hydroperoxides and inhibitors with human lipoxygenases
Bioorganic & Medicinal Chemistry 2013.0
Indole derivatives as potent inhibitors of 5-lipoxygenase: Design, synthesis, biological evaluation, and molecular modeling
Bioorganic & Medicinal Chemistry Letters 2007.0
Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases
Bioorganic & Medicinal Chemistry 2012.0
Synthesis of new heterocyclic lupeol derivatives as nitric oxide and pro-inflammatory cytokine inhibitors
Bioorganic & Medicinal Chemistry Letters 2014.0
Design and synthesis of carbamate and thiocarbamate derivatives and their inhibitory activities of NO production in LPS activated macrophages
Bioorganic & Medicinal Chemistry Letters 2012.0